Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/4741
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYakhyaeva K.Z., Iskanova G.X., Olimova R.R.-
dc.date.accessioned2022-12-09T06:23:39Z-
dc.date.available2022-12-09T06:23:39Z-
dc.date.issued2022-
dc.identifier.isbn978-1-83853-487-5 DOI-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/4741-
dc.description.abstractIn recent years, the progression of chronic glomerulonephritis (CGN) has been considered from the standpoint of the impact of a complex of modifiable and nonmodifiable factors, among which special attention is paid to the high activity of the disease, systemic and intraglomerular hypertension, hyperlipidemia and proteinuria. Most often, hyperlipidemia is considered as a secondary disorder resulting from changes in the filtration function of the kidneys.en_US
dc.language.isoen_USen_US
dc.publisherEnglanden_US
dc.titleThe role of lipid metabolism marks and atherogenicity index in children with GLOMERULONEFRITISen_US
dc.typeOtheren_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
ENGLAND september-october 2022.pdfThe role of lipid metabolism marks and atherogenicity index in children with GLOMERULONEFRITIS535.5 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.